NCT06878508Completed
DuoCor Ventricular Assist System Early Feasibility Study
Clincial Use of Implantable Ventricular Assist System for Advanced Heart Failure
Source: ClinicalTrials.gov · Last updated 24 Apr 2026
Brief summary (registry, in English)
Feasibility study of the DuoCor Ventricular Assist System as a treatment for advanced total heart failure patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 8 (actual)
- First submitted
- 6 Mar 2025
- Start date
- 4 Jul 2024
- Primary completion date
- 17 Mar 2025
- Lead sponsor
- Shenzhen Core Medical Technology CO.,LTD.
- Diseases
- Heart failure
- NCT number
- NCT06878508
What you commit to
- Study type: Interventional
- Participants enrolled: 8
- From 4 Jul 2024 to the primary completion date, 17 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Intolerance to anticoagulant or antiplatelet therapies or any other peri/post-operative therapy the investigator will require based upon the patient's health status.
Other illness
- Technical obstacles which pose the implantation as unsuitable, obtaining the body type, body surface area, and anatomical conditions related to the planned implantation site, in the judgment of the experienced investigators.
- Presence of an active, uncontrolled infection.
- History of confirmed, untreated abdominal aortic aneurysm (AAA) or thoracic aortic aneurysm (TAA) \> 5 cm in diameter.
- Irreversible cognitive dysfunction, psychosocial issues, or psychiatric disease, likely to impair compliance with the study protocol and DuoCor VAS management which, in the opinion of the investigator, could interfere with the ability to manage the therapy.
Age
- Age \> 75 years.
Other
- Pregnancy.
- Brain death.
Who the study is looking for
- Adult patients who require biventricular mechanical circulatory support, defined by either of the following criteria:
- Persistent total heart failure despite optimal medical management based on current heart failure practice guidelines; OR
- Development of refractory right heart failure following left ventricular assist device (LVAD) implantation, unresponsive to pharmacological interventions for right heart failure.
- Patient has signed the informed consent, has full understanding of procedures, and is committed to following study requirements.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Coordinator of this site? Confirm its status | Wuhan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.